Telix Pharmaceuticals (Innovations) Pty Ltd
3 clinical trials · Sponsor
◉ Watch Telix Pharmaceuticals (Innovations) Pty Ltd
| Record | Firm | Date |
|---|---|---|
| 89Zr-olaratumab Dosimetry in Participants With PDGFR Alpha Positive Solid Tumours and Soft Tissue Sarcoma (NCT06537596) | Telix Pharmaceuticals (Innovations) Pty Ltd | 2024-10-31 |
| The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only (NCT04876651) | Telix Pharmaceuticals (Innovations) Pty Ltd | 2023-08-29 |
| 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors (NCT05563272) | Telix Pharmaceuticals (Innovations) Pty Ltd | 2023-06-06 |
Track Telix Pharmaceuticals (Innovations) Pty Ltd automatically
Every clearance here is in the API, with alerts when new ones post.